Literature DB >> 11230638

Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine.

D Li1, J Zheng, H J Weinmann.   

Abstract

PURPOSE: To compare the efficacy of an intravascular contrast agent, gadomer-17, in improving magnetic resonance (MR) imaging of coronary arteries with that of an extravascular agent, gadopentetate dimeglumine, in pigs.
MATERIALS AND METHODS: Eight pigs underwent imaging after three injections: 0.20 mmol of gadopentetate dimeglumine per kilogram of body weight and 0.05 and 0.10 mmol/kg gadomer-17. Coronary images were acquired repeatedly after each injection by using an inversion-recovery-prepared segmented three-dimensional sequence with either breath holding (n = 4) or respiratory gating (n = 4). Coronary artery-to-myocardium contrast-to-noise ratios (CNRs) were compared between injections.
RESULTS: At breath-hold imaging, substantial CNR improvement over precontrast images was observed in images acquired during the first pass of gadopentetate dimeglumine in coronary arteries and up to 6 and 10 minutes after 0.05 and 0.10 mmol/kg of gadomer-17 injections, respectively. The CNR with 0.10 mmol/kg of gadomer-17 was 20% (P <.05) higher than that with gadopentetate dimeglumine at first-pass imaging. At respiratory-gated imaging, significant CNR improvement (P <.05) over precontrast images was observed in images acquired up to 10, 30, and 50 minutes after gadopentetate dimeglumine and both gadomer-17 injections, respectively. The CNR on the first images obtained after 0.10 mmol/kg gadomer-17 injection was 168% (P <.05) higher than that on the images obtained after gadopentetate dimeglumine injection.
CONCLUSION: Gadomer-17 provided greater and more persistent CNR improvements than did gadopentetate dimeglumine; further evaluation of its utility for coronary imaging in humans is warranted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230638     DOI: 10.1148/radiology.218.3.r01mr03670

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Toward comparability of coronary magnetic resonance angiography: proposal for a standardized quantitative assessment.

Authors:  Martijn S Dirksen; Hildo J Lamb; Rob van der Geest; Albert de Roos
Journal:  Eur Radiol       Date:  2003-08-02       Impact factor: 5.315

2.  Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.

Authors:  Clemens C Cyran; Yanjun Fu; Victor Rogut; Bundit Chaopathomkul; Michael F Wendland; David M Shames; Robert C Brasch
Journal:  Acad Radiol       Date:  2013-10       Impact factor: 3.173

3.  Magnetic resonance coronary angiography with Vasovist: in-vivo T1 estimation to improve image quality of navigator and breath-hold techniques.

Authors:  Kai Nassenstein; Kai-Uwe Waltering; Sebastian Kelle; Thomas Schlosser; Frank Breuckmann; Stefan Maderwald; Peter Hunold; Eike Nagel; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2007-08-14       Impact factor: 5.315

4.  Three-dimensional breathhold magnetization-prepared TrueFISP: a pilot study for magnetic resonance imaging of the coronary artery disease.

Authors:  Richard M McCarthy; Vibhas S Deshpande; Nirat Beohar; Sheridan N Meyers; Steven M Shea; Jordin D Green; Xin Liu; Xiaoming Bi; F Scott Pereles; John Paul Finn; Charles J Davidson; James C Carr; Debiao Li
Journal:  Invest Radiol       Date:  2007-10       Impact factor: 6.016

5.  Quantification of regional myocardial oxygenation by magnetic resonance imaging: validation with positron emission tomography.

Authors:  Kyle S McCommis; Thomas A Goldstein; Dana R Abendschein; Pilar Herrero; Bernd Misselwitz; Robert J Gropler; Jie Zheng
Journal:  Circ Cardiovasc Imaging       Date:  2009-11-20       Impact factor: 7.792

Review 6.  Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths.

Authors:  Akhila N W Kuda-Wedagedara; Matthew J Allen
Journal:  Analyst       Date:  2014-09-21       Impact factor: 4.616

7.  MR angiography of collateral arteries in a hind limb ischemia model: comparison between blood pool agent Gadomer and small contrast agent Gd-DTPA.

Authors:  Karolien Jaspers; Bas Versluis; Tim Leiner; Petra Dijkstra; Marlies Oostendorp; Jolanda M van Golde; Mark J Post; Walter H Backes
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

8.  Gadolinium-conjugated star-block copolymer polylysine-modified polyethylenimine as high-performance T 1 MR imaging blood pool contrast agents.

Authors:  Zhongjie Huang; Yicun Chen; Daojun Liu; Chao Lu; Zhiwei Shen; Shuping Zhong; Ganggang Shi
Journal:  RSC Adv       Date:  2018-01-30       Impact factor: 3.361

Review 9.  Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents.

Authors:  Zheng-Rong Lu; Aaron M Mohs; Yuda Zong; Yi Feng
Journal:  Int J Nanomedicine       Date:  2006

Review 10.  Gadofosveset-enhanced magnetic resonance angiography.

Authors:  Mathias Goyen
Journal:  Vasc Health Risk Manag       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.